Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

11,140

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Perindopril-indapamide

DRUG

Gliclazide MR-based glucose lowering

Trial Locations (5)

3010

The University of Melbourne, Melbourne

100037

Cardiovascular Institute & Fu Wai Hospital, Beijing

H26 1X2

University of Montreal, Montreal

3508 BA

The Julius Center for Health Sciences and Primary Care, Utrecht

W2 1PG

Imperial College School of Medicine, London

All Listed Sponsors
collaborator

Institut de Recherches Internationales Servier

OTHER

collaborator

University of Sydney

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

lead

The George Institute

OTHER

NCT00145925 - Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter